DGAP-CMS: CompuGroup Medical SE: Release of a capital market information

2019. szeptember 30., hétfő, 11:02







DGAP Post-admission Duties announcement: CompuGroup Medical SE


/ Share Buyback






CompuGroup Medical SE: Release of a capital market information


30.09.2019 / 11:02


Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.



CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 2nd Interim Announcement



CompuGroup Medical SE / Share Buyback



 



Koblenz, September 30, 2019



CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 2nd Interim Announcement



In the period from September 23, 2019, up to and including September 27, 2019, CompuGroup Medical SE has bought back a total of 86,411 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of September 17, 2019, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on September 18, 2019.



The overall volume of the shares bought back daily in the period from September 23, 2019, up to and including September 27, 2019, and the daily volume-weighted average stock market prices of the shares are as follows:



























Date Overall volume of shares bought back (number) Volume-weighted average stock market price
(EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice)
September 23, 2019 23,750 54.6102
September 24, 2019 19,114 54.1513
September 25, 2019 16,257 54.3942
September 26, 2019 19,410 55.0118
September 27, 2019 7,880 55.4148
     
In total: 86,411 54.6316

 

The total number of shares which have been bought back so far by CompuGroup Medical SE since September 18, 2019, up to and including September 27, 2019, within the framework of the share buyback program thus amounts to 133,063 no-par value shares.



Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.



The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).



Koblenz, September 30, 2019



The Management Board



CompuGroup Medical SE

Investor Relations

Maria Trost 21

56070 Koblenz, Germany

T: 49 (0) 261 8000-6200

F: 49 (0) 261 8000-3200
















30.09.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de













Language: English
Company: CompuGroup Medical SE

Maria Trost 21

56070 Koblenz

Germany
Internet: www.cgm.com





 
End of News DGAP News Service





882427  30.09.2019 



fncls.ssp?fn=show_t_gif&application_id=882427&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum